NCT02622659

The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 468 (actual)
• Sponsor: Guangzhou Yipinhong Pharmaceutical CO.,LTD · Industry
• Sex: All
• Age: 1 Year – 12 Years
• Healthy volunteers: Not accepted

Summary

Randomized, double blind, double dummy, positive drug parallel comparison, multi-centre clinical trial to assess the efficacy and safety of Fuganlin Oral Liquid in children with influenza (acute upper respiratory infection).

Detailed description

Treatment group: Fuganlin Oral Liquid 10mL. Control group: Xiaoer Jiebiao oral liquid 100mL. Treatment for one week. Patients who were recovered within one week can withdrawal at any time.

Conditions

• Acute Upper Respiratory Infection

Interventions

Type	Name	Description
DRUG	Fuganlin Oral Liquid	less than 1 years old: 5mL each time and three times a day 1\~3 years old: 10mL each time and three times a day 4\~6 years old: 10mL each time and four times a day 7\~12 years old: 10mL each time and five times a day
DRUG	Xiaoer Jiebiao Oral Liquid	1\~2 years old: 5mL each time and twice a day 3\~5 years old: 5mL each time and three times a day 6\~14 years old: 10mL each time and twice a day

Timeline

• Start date: 2012-03-01
• Primary completion: 2014-03-01
• Completion: 2014-03-01
• First posted: 2015-12-04
• Last updated: 2017-05-22

Locations

1 site across 1 country: China